Who owns the PIONEERING EXONEURAL MEDICINES trademark?

The PIONEERING EXONEURAL MEDICINES trademark is owned by Cygnal Therapeutics, Inc..

What class is the PIONEERING EXONEURAL MEDICINES trademark registered in?

The PIONEERING EXONEURAL MEDICINES trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for PIONEERING EXONEURAL MEDICINES?

The USPTO serial number for PIONEERING EXONEURAL MEDICINES is 90280802.

What is the registration number for PIONEERING EXONEURAL MEDICINES?

PIONEERING EXONEURAL MEDICINES is registered under USPTO registration number 0.

PIO

USPTO Trademark Record

ABANDONED

PIONEERING EXONEURAL MEDICINES

SN 90280802·Reg 0·Filed Oct 27, 2020

Owner Cygnal Therapeutics, Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PIONEERING EXONEURAL MEDICINES (Serial No. 90280802), Registration No. 0, is a abandoned US trademark filed on Oct 27, 2020 by Cygnal Therapeutics, Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

PIONEERING EXONEURAL MEDICINES (Reg. #0) is an abandoned US trademark that was filed in 2020 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 27, 2020

SERIAL

90280802

REG#

Owner

Applicant

Cygnal Therapeutics, Inc.

Entity

Corporation

State

Address

325 Vassar Street, Suite 2B, Cambridge, MA, 02139

Country

Attorney

NameChristina M. Licursi

Law firm

Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.

Docket

V03062000700

Address

600 ATLANTIC AVENUE, BOSTON, MA 02210-2206, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateOct 27, 2020

Serial Number90280802

Registration No.0

Status DateOct 10, 2022

Published for OppositionJan 11, 2022

Mark TypeStandard characters

Attorney DocketV03062000700

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

20 events

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 11, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

ABANDONMENT - NO USE STATEMENT FILED

Oct 10, 2022

ABANDONMENT - NO USE STATEMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 08, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jan 11, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 11, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 22, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Dec 09, 2021

ASSIGNED TO LIE

ASSIGNED TO EXAMINER

Dec 08, 2021

ASSIGNED TO EXAMINER

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 08, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 30, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 30, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 30, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Mar 31, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Mar 31, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 31, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Mar 27, 2021

ASSIGNED TO EXAMINER

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Mar 26, 2021

TEAS CHANGE OF OWNER ADDRESS RECEIVED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 26, 2021

TEAS CHANGE OF CORRESPONDENCE RECEIVED

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Mar 26, 2021

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 16, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

PIONEERING EXONEURAL MEDICINES

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Cygnal Therapeutics, Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Christina M. Licursi

Resources

Company